About Oscar Health, Inc.
https://www.hioscar.comOscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products.
CEO
Mark Thomas Bertolini
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 138
Ratings Snapshot
Rating : D+
Most Recent Analyst Grades
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:20.16M
Value:$336.48M
BLACKROCK, INC.
Shares:16.19M
Value:$270.15M
BLACKROCK INC.
Shares:14.18M
Value:$236.58M
Summary
Showing Top 3 of 364
About Oscar Health, Inc.
https://www.hioscar.comOscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.99B ▲ | $3.12B ▲ | $-137.45M ▲ | -4.6% ▲ | $-0.53 ▲ | $-125.12M ▲ |
| Q2-2025 | $2.86B ▼ | $3.09B ▲ | $-228.36M ▼ | -7.97% ▼ | $-0.89 ▼ | $-220.72M ▼ |
| Q1-2025 | $3.05B ▲ | $2.76B ▲ | $275.27M ▲ | 9.04% ▲ | $1.1 ▲ | $300.94M ▲ |
| Q4-2024 | $2.39B ▼ | $2.55B ▲ | $-153.55M ▼ | -6.42% ▼ | $-0.62 ▼ | $-138.43M ▼ |
| Q3-2024 | $2.42B | $2.48B | $-54.6M | -2.25% | $-0.22 | $-39M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $3.04B ▼ | $5.75B ▼ | $4.72B ▼ | $1.02B ▼ |
| Q2-2025 | $3.54B ▲ | $6.38B ▲ | $5.22B ▲ | $1.16B ▼ |
| Q1-2025 | $2.99B ▲ | $5.84B ▲ | $4.51B ▲ | $1.33B ▲ |
| Q4-2024 | $2.15B ▲ | $4.84B ▲ | $3.82B ▲ | $1.01B ▼ |
| Q3-2024 | $1.71B | $4.48B | $3.32B | $1.16B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-137.45M ▲ | $-964.66M ▼ | $150.08M ▲ | $364.03M ▲ | $-450.08M ▼ | $-973.66M ▼ |
| Q2-2025 | $-228.49M ▼ | $509.07M ▼ | $-168.21M ▲ | $22.13M ▲ | $362.99M ▼ | $499.79M ▼ |
| Q1-2025 | $275.51M ▲ | $878.54M ▲ | $-174.23M ▼ | $4.87M ▲ | $709.19M ▲ | $869.52M ▲ |
| Q4-2024 | $-153.28M ▼ | $346.82M ▲ | $-31.45M ▲ | $3.82M ▼ | $319.19M ▲ | $340M ▲ |
| Q3-2024 | $-54.17M | $-500.14M | $-577.77M | $18.56M | $-1.06B | $-507.71M |
CEO
Mark Thomas Bertolini
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 138
Ratings Snapshot
Rating : D+
Most Recent Analyst Grades
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:20.16M
Value:$336.48M
BLACKROCK, INC.
Shares:16.19M
Value:$270.15M
BLACKROCK INC.
Shares:14.18M
Value:$236.58M
Summary
Showing Top 3 of 364